Design of lonzymes for prodrug-based cancer therapy
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/143742 |
Resumo: | Cancer is one of the major public health issues in the world, being one of the principal causes of death around the world. Different cancer treatments have been extensively studied in the past years, being nanomedicine one of the latest approaches with tremendous potential, studied by various research groups for cancer therapy. Different types of nanoparticles can be used for different methods, and have different properties. Some of the different types of na-noparticles being studied for cancer treatment are inorganic nanoparticles, organic nanopar-ticles, polymeric nanoparticles like chitosan nanoparticles and iron oxide nanoparticles. In this work, we have evaluated the peroxidase-like activity of iron oxide nanoparticles to convert paracetamol to its` cytotoxic form, in order to kill cancer cells. And in order to use the peroxidase-like activity of iron oxide nanoparticles with paracetamol, we incorporated the prodrug and the iron oxide nanoparticles by coating them with chitosan using the ionotropic gelation technique. After we optimized the encapsulation process and achieved homogeneous suspensions of nanoparticles coated with chitosan and with 55% of encapsulation efficiency of the drug, the obtained nanoparticles were characterized in terms of their constitution and cytotoxicity. The characterization results confirmed the presence of paracetamol in the ob-tained nanoparticles, and that the incorporation of paracetamol didn`t significantly change the physical and chemical properties of iron oxide nanoparticles coated with chitosan. The cytotoxicity results showed no significant cytotoxicity of nanoparticles with paracetamol when compared with nanoparticles without paracetamol, leading us to conclude that parace-tamol was either not converted to its cytotoxic form by peroxidase-like activity, or was not converted to the extent required for a cytotoxic effect. |
id |
RCAP_4b7efa0dc173c16db13faa47b3627333 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/143742 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Design of lonzymes for prodrug-based cancer therapyiron oxide nanoparticlesparacetamolperoxidase-like activitychitosanionotropic gelationDomínio/Área Científica::Engenharia e Tecnologia::NanotecnologiaCancer is one of the major public health issues in the world, being one of the principal causes of death around the world. Different cancer treatments have been extensively studied in the past years, being nanomedicine one of the latest approaches with tremendous potential, studied by various research groups for cancer therapy. Different types of nanoparticles can be used for different methods, and have different properties. Some of the different types of na-noparticles being studied for cancer treatment are inorganic nanoparticles, organic nanopar-ticles, polymeric nanoparticles like chitosan nanoparticles and iron oxide nanoparticles. In this work, we have evaluated the peroxidase-like activity of iron oxide nanoparticles to convert paracetamol to its` cytotoxic form, in order to kill cancer cells. And in order to use the peroxidase-like activity of iron oxide nanoparticles with paracetamol, we incorporated the prodrug and the iron oxide nanoparticles by coating them with chitosan using the ionotropic gelation technique. After we optimized the encapsulation process and achieved homogeneous suspensions of nanoparticles coated with chitosan and with 55% of encapsulation efficiency of the drug, the obtained nanoparticles were characterized in terms of their constitution and cytotoxicity. The characterization results confirmed the presence of paracetamol in the ob-tained nanoparticles, and that the incorporation of paracetamol didn`t significantly change the physical and chemical properties of iron oxide nanoparticles coated with chitosan. The cytotoxicity results showed no significant cytotoxicity of nanoparticles with paracetamol when compared with nanoparticles without paracetamol, leading us to conclude that parace-tamol was either not converted to its cytotoxic form by peroxidase-like activity, or was not converted to the extent required for a cytotoxic effect.O cancro é um dos maiores problemas de saúde pública no mundo, sendo uma das principais causas de morte no mundo inteiro. Diferentes tratamentos para o cancro têm sido extensivamente estudados nos últimos anos, sendo a nanomedicina uma das mais recentes abordagens com um tremendo potencial a ser estudada por vários grupos para o tratamento do cancro. Diferentes tipos de nanopartículas podem ser usadas no tratamento do cancro, em diferentes métodos e com diferentes propriedades. Algumas das diferentes nanopartículas a serem estudadas para o tratamento do cancro são as nanopartículas inorgânicas, nanopartí-culas orgânicas, nanopartículas poliméricas como por exemplo nanopartículas de quitosano, e nanopartículas de óxido de ferro. Neste trabalho, tentámos avaliar a atividade de peroxidase das nanopartículas de óxido de ferro para converter paracetamol na sua forma citotóxica, de forma a poder matar células cancerígenas. E de modo a usar a atividade de peroxidase das nanopartículas de óxido de ferro com o paracetamol, incorporámos as nanopartículas e o fármaco ao revesti-los com qui-tosano usando a técnica de gelação ionotrópica. Depois de obtermos suspensões homogéneas de nanopartículas revestidas com quitosano e com uma eficiência de encapsulação de 55% do fármaco, caraterizámo-las em termos da sua constituição e citotoxicidade. Os resultados da caraterização confirmaram a presença de paracetamol nas nanopartículas obtidas, e que a in-corporação de paracetamol não alterou de forma significativa as propriedades físicas e quími-cas das nanopartículas de óxido de ferro encapsuladas com quitosano. Os resultados de cito-toxicidade não apresentaram citotoxicidade significativa por parte das nanopartículas com paracetamol quando comparadas com nanopartículas sem paracetamol, levando-nos a con-cluir que não houve conversão do paracetamol na sua forma citotóxica por atividade da pe-roxidase.Borges, JoãoBarreiros, SusanaRUNRusso, André2022-09-15T12:07:01Z2022-022022-02-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/143742enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:22:27Zoai:run.unl.pt:10362/143742Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:51:07.423659Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Design of lonzymes for prodrug-based cancer therapy |
title |
Design of lonzymes for prodrug-based cancer therapy |
spellingShingle |
Design of lonzymes for prodrug-based cancer therapy Russo, André iron oxide nanoparticles paracetamol peroxidase-like activity chitosan ionotropic gelation Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia |
title_short |
Design of lonzymes for prodrug-based cancer therapy |
title_full |
Design of lonzymes for prodrug-based cancer therapy |
title_fullStr |
Design of lonzymes for prodrug-based cancer therapy |
title_full_unstemmed |
Design of lonzymes for prodrug-based cancer therapy |
title_sort |
Design of lonzymes for prodrug-based cancer therapy |
author |
Russo, André |
author_facet |
Russo, André |
author_role |
author |
dc.contributor.none.fl_str_mv |
Borges, João Barreiros, Susana RUN |
dc.contributor.author.fl_str_mv |
Russo, André |
dc.subject.por.fl_str_mv |
iron oxide nanoparticles paracetamol peroxidase-like activity chitosan ionotropic gelation Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia |
topic |
iron oxide nanoparticles paracetamol peroxidase-like activity chitosan ionotropic gelation Domínio/Área Científica::Engenharia e Tecnologia::Nanotecnologia |
description |
Cancer is one of the major public health issues in the world, being one of the principal causes of death around the world. Different cancer treatments have been extensively studied in the past years, being nanomedicine one of the latest approaches with tremendous potential, studied by various research groups for cancer therapy. Different types of nanoparticles can be used for different methods, and have different properties. Some of the different types of na-noparticles being studied for cancer treatment are inorganic nanoparticles, organic nanopar-ticles, polymeric nanoparticles like chitosan nanoparticles and iron oxide nanoparticles. In this work, we have evaluated the peroxidase-like activity of iron oxide nanoparticles to convert paracetamol to its` cytotoxic form, in order to kill cancer cells. And in order to use the peroxidase-like activity of iron oxide nanoparticles with paracetamol, we incorporated the prodrug and the iron oxide nanoparticles by coating them with chitosan using the ionotropic gelation technique. After we optimized the encapsulation process and achieved homogeneous suspensions of nanoparticles coated with chitosan and with 55% of encapsulation efficiency of the drug, the obtained nanoparticles were characterized in terms of their constitution and cytotoxicity. The characterization results confirmed the presence of paracetamol in the ob-tained nanoparticles, and that the incorporation of paracetamol didn`t significantly change the physical and chemical properties of iron oxide nanoparticles coated with chitosan. The cytotoxicity results showed no significant cytotoxicity of nanoparticles with paracetamol when compared with nanoparticles without paracetamol, leading us to conclude that parace-tamol was either not converted to its cytotoxic form by peroxidase-like activity, or was not converted to the extent required for a cytotoxic effect. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-09-15T12:07:01Z 2022-02 2022-02-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/143742 |
url |
http://hdl.handle.net/10362/143742 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138106211827712 |